Cell Sciences 代理

详细介绍

产品咨询

世界*实验材料供应商 Cell Sciences 上海金畔生物为其中国代理， Cell Sciences 在一直是行业的*,一直为广大科研客户提供zui为优质的产品和服务,上海金畔生物一直秉承为中国科研客户带来的产品，的服务， Cell Sciences 就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获

 Cell Sciences 中国代理, Cell Sciences 上海代理， Cell Sciences 北京代理，Cell Sciences 广东代理， Cell Sciences 江苏代理Cell Sciences 湖北代理,Cell Sciences 天津,Cell Sciences 黑龙江代理,Cell Sciences 内蒙古代理,Cell Sciences 吉林代理,Cell Sciences 福建代理, Cell Sciences 江苏代理, Cell Sciences 浙江代理, Cell Sciences 四川代理,

Stem Cell Sciences

Stem Cell Sciences  www.stemcellsciences.com
Company profile
We are one of the first, if not the first, organisation with the R&D know-how, to develop a range of derived stem cells for use on a commercial and industrial scale.
Founded in 1994, we pioneered many of the unique technologies required to grow, differentiate, and purify embryonic and neural stem cells. Today we hold an extensive portfolio of patents and patent applications in both adult and embryonic stem cell fields. For example we were first with our neural stem cell technology to enable the derivation and growth of SCS’s patented NS cells – the first, mammalian tissue stem cells of any kind that can be stably grown outside the body as pure stem cells.

Our technologies permit the generation of highly purified stem cells and their differentiated progeny for use in genetic, pharmacological and toxicological screens. Moreover, these technologies can be utilised to provide pure populations of appropriate cell types for transplantation therapies. international biotechnology and pharmaceutical companies including Pfizer, Sanofi-Aventis, GSK, Chemicon, Deltagen and Lexicon have benefited from our commercial and industrial approach.

SCS takes pride in its long-standing relationships with leading academic centres of excellence in the stem cell field, which help maintain our position at the cutting edge of the stem cell industry.

This legacy is your assurance of quality, consistency in high volume, and a guaranteed supply of stem cells for use in research and drug discovery. As stem cell-based therapies and regenerative medicine move from the laboratory to the clinic, only SCS is equipped with a highly automated environment to meet the upsurge in demand.

We are headquartered in Cambridge, UK in a new, fully equipped cell culture facility featuring state of the art automation for cell culture, in the form of the CompacT SelecT™ from  The Automation Partnership as well as cell analysis equipment. Our NS cells are the first adherent brain stem cells to be grown on CompacT SelecT™. We also have a business development office in California （USA） and a research operation in Australia. We listed on AIM of the London Stock Exchange （LSE） in 2005 and on the Australian Securities Exchange （ASX） in 2007.

上海金畔生物科技有限公司
：